Biotechnological Drugs: World Trade, Markets and Competitors

Biotechnological Drugs: World Trade, Markets and Competitors

In 2021 world trade of Biotechnological drugs recorded a value of 245.6 Bn $ (+16.9% compared to 2020).

Worldwide flows of Biotechnological drugs recorded a Compound Annual Growth Rate (CAGR) in $ of +25.8% in the period 2001-2008 and of +13.2% in the period 2009-2020.

In the 2022-2025 scenario, world trade of Biotechnological drugs is expected to have a CAGR of +7.4% in $.

The report includes an analysis of 18 major importing countries of Biotechnological drugs, as regards:

import size and evolution both in values and volumes over the period 1995-2021
import segmentation by price-ranges and evolution 2021 vs 2011
import shares and price positioning by partner countries (competitors) in 2016-2021
forecast of import values and shares by competitors up to 2025

The report also includes an analysis of 20 major exporting countries of Biotechnological drugs, as regards:

export size and evolution both in values and volumes over the period 1995-2021
export segmentation by price-ranges and evolution 2021 vs 2011
export shares and price positioning by destination countries (markets) in 2016-2021
forecast of export values and shares by markets up to 2025.

Information contained in this report is derived from the Ulisse Database (available on www.exportplanning.com), that was developed from the UN(Comtrade), Eurostat (db Comext) and US Census Bureau (db UsaTrade) databases.The Ulisse Database basic unit is the Annual Flow of World Trade between two partner countries for Biotechnological Drugs.Forecasts contained in this report have been developed by StudiaBo from the Ulisse Database andthe World Economic Outlook (WEO) database, periodically released by the International Monetary Fund.Forecasts are the output of an integrated econometric model of demand and competitiveness, thatis based on expected macroeconomic trends and capacity of countries to compete in internationalmarkets. They provide a robust estimate of the scenario of Biotechnological Drugs’ world trade.